Navigation Links
Unborn Found To Be More Sensitive to Pollution

Unborn babies are particularly sensitive to cancer-causing pollutants found in the air, report researchers who studied pregnant women and their newborn babies // .Past studies in mice have shown exposure to pollutants is more harmful to fetuses than their mothers, despite the fact the placenta filters out most of the pollutants. These researchers wondered if the same was true in humans.

Researchers collected blood samples from 265 mothers and their newborn babies looking for biomarkers indicating exposure to proteins known as carcinogen-DNA adducts, and cotinine, a component of cigarette smoke. All mothers in the study were nonsmokers.

Even though the mothers were exposed to 10-times more of the pollutants, the newborns had evidence of DNA damage comparable to that found in their mothers. The infants actually had more cotinine in their systems than their mothers, suggesting exposure to secondhand smoke is especially dangerous for pregnant women.

These results raise serious concern,say researchers and they caution that fetal susceptibility to DNA damage from air pollution, including motor vehicle emissions and secondhand smoke, has important implications for cancer risk and developmental problems.
'"/>




Page: 1

Related medicine news :

1. Unborn babies respond to light
2. Drugs Taken During Pregnancy Found To Affect Unborn Babies
3. Antidepressants Late In Pregnancy Harmful to Unborn Baby
4. Mother’s Diet Could Prevent Cancer In Their Unborn Children
5. Stressed Pregnant Working Mothers Put Their Unborn Child’s Life in Dange
6. Fluoride Found Effective in Osteoporosis
7. Implantable Contact Lens Found Safe and Effective
8. Cancer hazard Found With Animal-Based Nutrients
9. Processed Meat, Diabetes connection Found
10. Night Time Aspirin Regimen Found to Reduce Blood Pressure
11. Hydrotherapy Found to be Effective for Patients with Osteoarthritis

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Unborn Found More Sensitive Pollution

(Date:11/27/2009)...Nov.27/PRNewswire-FirstCall/--TheGymboreeCorporati...,willpresentattheNASDAQOMX23rdInvestorProgram,whic...nesday,December2,2009,at11:45a.m.GMT. ,, Tolist...tationovertheInternet,pleaselogontowww.gymboree.co...estorandMediaRelations"andthen"ConferenceCalls&...
(Date:11/27/2009)... XenaCare Holdings has announced that it has b...on, one of the largest nonprofit organizations ded...cation. , Delray Beach, F...Inc. (OTCBB: XCHO), a company specializing in the ...thcare products, has announced today that is has b...
(Date:11/27/2009)... Voyant Health™ announced today that Spe... its TraumaCad Enterprise orthopedic templating so... , (PRWEB) November 27, 2...pectrum Health (Grand Rapids, Michigan) has licens...solution and its TraumaCad Extend workflow solutio...
(Date:11/26/2009)...7/PRNewswire/--Withcoldandfluseasonuponus,it,smore...spreadofinfectionsandavoidillness. ,, "Weneedto...dtransmittingillnessifwe,resick,"saidEileenFinerty...rectorforinfectioncontrolandoccupationalhealthatHo...pitalforSpecialSurgeryhasoneofthelowestinfectionra...
(Date:11/26/2009)...g or too heavy can lead to strains or worse , ...e may be nothing wrong with stuffing your turkey f...same thing with your suitcase as you pack for holi...ed in 2008 in U.S. hospital emergency rooms, docto...for luggage-related injuries, such as muscle strai...
Breaking Medicine News(10 mins):Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Pack Right for the Holidays to Avoid the ER 2
..., C-section deliveries also hit new high last year... For the first time in 14 years, the number of tee...t year, according to a new government report relea...babies as well as for Caesarean deliveries. , The ...
... years, study suggests , , WEDNESDAY, Nov....the biological underpinnings of "senior moments," ...erent parts of the brain begins to break down as a...ology at Harvard University. "We were interested i...
...oday with,security analysts, Diane H. Gulyas, grou...discussed the segment,s growth and productivity,st...s, the DuPont,Performance Materials platform is de...tion markets., "We have delivered strong revenue ...
... corporations and their,insurance companies pay ou...ttlements and jury awards for mass-tort cases by w... chemicals. Now a new DNA technology promises to,w...nd resolutions., Dr. Bruce Gillis, CEO of the gen...
...e Products, Inc., a,business specializing in patie... mobile lifts and safe patient handling programs, ...ess Enterprise by the Women,s Business,Development...prnh/20071204/MEDCAREPRODUCTS ), WBENC,s national...
... new technique for detecting a painful nerve condi...f people with diabetes and many other patients as ...ructures in the skin known as Meissner corpuscles,...of your hand, or gives you a kiss its Meissner co...
Other Medicine News:Health News:Teen Birth Rates Up for First Time in 14 Years, U.S. Reports 2Health News:Teen Birth Rates Up for First Time in 14 Years, U.S. Reports 3Health News:Aging Brains Get Out of Sync 2Health News:Aging Brains Get Out of Sync 3Health News:DuPont Group Vice President Briefs Investors on Performance Materials Segment 2Health News:ABA Conference in Chicago Provides Litigators First Look at DNA Technology That Can Save Millions in Workers Comp and Toxic Tort Cases 2Health News:Patient Lift Manufacturer, Medcare Products, Obtains Women-Owned Certification 2Health News:A pain-free window into painful neuropathies 2Health News:A pain-free window into painful neuropathies 3Health News:A pain-free window into painful neuropathies 4
(Date:11/25/2009)...5/PRNewswire/--TheFDAgrantedtraditionalapprovalfor...reversetranscriptaseinhibitor(NNRTI).INTELENCEisth...xperiencedadultswhoareexperiencingvirologicfailure...oviral(ARV)agents.Thetraditionalapprovalisbasedon4...-2.INTELENCEiscurrentlymarketedintheU.S.byTibotecT...
(Date:11/25/2009)...ov.25/PRNewswire/--AMPACFineChemicalsLLC(AFC),asub...announcedtodaythatitreceivedtheEnvironmentalRespon...EnvironmentalSummit,sponsoredbytheCaliforniaManufa...lEnvironmentalAssociation(IEA)andtheChemicalIndust...emostprestigiousawardavailablefromallthreeorganiza...
(Date:11/25/2009)...ire/--Reportlinker.comannouncesthatanewmarketresea...tatesDentalDevicesMarketAnalysisandForecaststo2015...ed-States-Dental-Devices-Market-Analysis-and-Forec...MarketAnalysisandForecaststo2015 ,, Summary ,...mationanddatarelatingtotheUSdentaldevicesmarket.It...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12REMOXY 28R 29 NDA Update 50869 1REMOXY 28R 29 NDA Update 50869 2REMOXY 28R 29 NDA Update 50869 3REMOXY 28R 29 NDA Update 50869 4New Software Makes Lawyers Accountable for Their Part in Our Healthcare Crisis 50866 1New Software Makes Lawyers Accountable for Their Part in Our Healthcare Crisis 50866 2AEterna Zentaris 3A New Data Published on its Ghrelin Antagonist Compound AEZS 123 28JMV2959 29 Supports its Use in Alcohol Addiction 12909 1AEterna Zentaris 3A New Data Published on its Ghrelin Antagonist Compound AEZS 123 28JMV2959 29 Supports its Use in Alcohol Addiction 12909 2AEterna Zentaris 3A New Data Published on its Ghrelin Antagonist Compound AEZS 123 28JMV2959 29 Supports its Use in Alcohol Addiction 12909 3AEterna Zentaris 3A New Data Published on its Ghrelin Antagonist Compound AEZS 123 28JMV2959 29 Supports its Use in Alcohol Addiction 12909 4
...e American Heart Association Scientific Sessions ...OCA RATON, Fla., Nov. 7 Nabi,Biopharmaceuticals (...pletion,of its Phase 2b trial of NicVAX(R) (Nicoti...d proprietary investigational vaccine being,develo...g relapse. The,final 12-month data confirm the hig...
...asense(R) in melanoma opens to global accrual ...ne disease - Named-patient/compassionate-use p...o review FDA decision on Genasense in CLL, - Brief...d in new clinical ...rporated (Nasdaq: GNTA ) today reported financial...
Other Medicine Technology:Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 2Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 3Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 4Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 5Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 6Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 7Genta Incorporated Announces Third Quarter 2007 Financial Results 2Genta Incorporated Announces Third Quarter 2007 Financial Results 3Genta Incorporated Announces Third Quarter 2007 Financial Results 4Genta Incorporated Announces Third Quarter 2007 Financial Results 5Genta Incorporated Announces Third Quarter 2007 Financial Results 6Genta Incorporated Announces Third Quarter 2007 Financial Results 7
...SphygmoCor Px Central Blood Pressure Assessment an...ive method of obtaining central blood pressure and... enhance the treatment and management of patients....ction, the system derives the ascending aortic blo...
Genetic Systems HIV-1/HIV-2 PLUS O EIA (detects Ab to HIV-1 (M+O) and HIV-2)
Microspeed EC
Shandon High-Capacity Section Dryer
Medicine Products: